8 results
Stages in the development of HF and recommended therapy by stage. ACEI indicates angiotensin-converting enzyme inhibitor;
inhibitor; AF, atrial fibrillation ... angiotensin-receptor blocker ... ejection fraction; HFrEF ... ACCAHA #Algorithm #Management ... #Cardiology
Atrial Fibrillation RVR - Medications
Diltiazem
 • Preferred in patients with chronic lung such as Asthma and
Atrial Fibrillation ... strongly consider using ... #Atrial #Fibrillation ... #Medications #management ... #treatment #comparison
Pharmacology of diuretics

Acetazolamide, Loop diuretics, Thiazide‐like diuretics, MRA, Amiloride

Site of Action, Maximum Dose, Half-Life, Onset, Bioavailability,
Pharmacology of ... #Comparison #Table ... #HalfLife #Dosing ... Thiazide #CHF #Cardiology ... #Management
Intern Pocket Cards - Inpatient Blood Pressure Management Guide
ß-blockers:
 • Metoprolol, Carvedilol, Labetalol
 • Bradycardia, heart
Blood Pressure Management ... Guide ß-blockers ... Amlodipine • HFrEF ... medications #Inpatient #pharmacology ... agents #internship #comparison
Heart Failure (HFrEF) Treatment - GDMT for stage C 

For patients with Heart Failure with REDUCED
evidenced beta-blocker ... ACEI/ARB + Beta-Blocker ... #Pharmacology # ... Management #Treatment ... #StageC #Cardiology
Acute Atrial Fibrillation - Initial Options for Rate Control
Diltiazem IV
 •  Rapid onset and rapidly
Acute Atrial Fibrillation ... Beneficial in HFrEF ... EricsMedicalLectures/ #Atrial #Fibrillation ... Rate #Control #pharmacology ... #management #cardiology
Heart failure with Reduced Ejection Fraction (HFrEF)
Clinical Presentation
1. Typical symptoms: dyspnea, orthopnea paroxysmal noctumal dyspnea, fatigue,
Ejection Fraction (HFrEF ... endomyocardial biopsy Pharmacology ... inhibitors) • ß-Blockers ... heartfailure #diagnosis #management ... #cardiology #pharmacology
Management of Anthracyclines and HER2 Antagonist Cardiotoxicity
Anthracyclines cause cardiomyopathy:
 ✖ Reduction in left ventricular ejection fraction
Management of Anthracyclines ... inhibitor, beta blocker ... every 3 months during ... Cardiotoxicity #cardiology ... #oncology #pharmacology